|
9535 | 9535 | }, |
9536 | 9536 | "description": "VO is a biomedical ontology in the domain of vaccine and vaccination.", |
9537 | 9537 | "domain": "health", |
9538 | | - "homepage": "http://www.violinet.org/vaccineontology", |
| 9538 | + "homepage": "https://violinet.org/vaccineontology", |
9539 | 9539 | "id": "vo", |
9540 | 9540 | "layout": "ontology_detail", |
9541 | 9541 | "license": { |
9542 | | - "label": "CC BY 3.0", |
| 9542 | + "label": "CC BY 4.0", |
9543 | 9543 | "logo": "http://mirrors.creativecommons.org/presskit/buttons/80x15/png/by.png", |
9544 | | - "url": "http://creativecommons.org/licenses/by/3.0/" |
| 9544 | + "url": "http://creativecommons.org/licenses/by/4.0/" |
9545 | 9545 | }, |
9546 | 9546 | "ontology_purl": "http://purl.obolibrary.org/obo/vo.owl", |
9547 | 9547 | "preferredPrefix": "VO", |
|
9563 | 9563 | ], |
9564 | 9564 | "repository": "https://github.com/vaccineontology/VO", |
9565 | 9565 | "title": "Vaccine Ontology", |
9566 | | - "tracker": "https://github.com/vaccineontology/VO/issues" |
| 9566 | + "tracker": "https://github.com/vaccineontology/VO/issues", |
| 9567 | + "usages": [ |
| 9568 | + { |
| 9569 | + "description": "VIOLIN uses VO to standardize vaccine information", |
| 9570 | + "examples": [ |
| 9571 | + { |
| 9572 | + "description": "VIOLIN using VO grouped all SARS-CoV-2 vaccines", |
| 9573 | + "url": "https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5339" |
| 9574 | + }, |
| 9575 | + { |
| 9576 | + "description": "A specific vaccine ‘Allogeneic Tumor Cell Vaccine’ curated in VO for VIOLIN vaccine record", |
| 9577 | + "url": "https://violinet.org/vaxquery/query_detail.php?c_pathogen_id=321#vaccine_5878" |
| 9578 | + } |
| 9579 | + ], |
| 9580 | + "user": "https://violinet.org" |
| 9581 | + }, |
| 9582 | + { |
| 9583 | + "description": "Vaccine Adjuvant Compendium (VAC) uses Vaccine Ontology to standard vaccine adjuvants developed by NIH", |
| 9584 | + "examples": [ |
| 9585 | + { |
| 9586 | + "description": "A specific vaccine adjuvant, such as CaPNP (CaPtivant)(TM), in Vaccine Adjuvant Compendium, uses VO_0005295 ‘CaPNP (CaPtivant)(TM) vaccine adjuvant’", |
| 9587 | + "url": "https://vac.niaid.nih.gov/view?id=11" |
| 9588 | + } |
| 9589 | + ], |
| 9590 | + "user": "https://www.niaid.nih.gov/research/vaccine-adjuvant-compendium-vac" |
| 9591 | + }, |
| 9592 | + { |
| 9593 | + "description": "ImmPort uses Vaccine Ontology to standardize vaccine recorded collected in NIH funded ImmPort studies", |
| 9594 | + "examples": [ |
| 9595 | + { |
| 9596 | + "description": "ImmPort data used VO for annotation shown in its dataModel", |
| 9597 | + "url": "https://www.immport.org/shared/dataModel" |
| 9598 | + } |
| 9599 | + ], |
| 9600 | + "user": "https://www.immport.org/" |
| 9601 | + }, |
| 9602 | + { |
| 9603 | + "description": "Human Immunology Project Consortium (HIPC) uses VO to standardize vaccine records", |
| 9604 | + "examples": [ |
| 9605 | + { |
| 9606 | + "description": "Influenza Vaccine Live, Intranasal used VO_0000044", |
| 9607 | + "url": "http://www.hipc-dashboard.org/#vaccine/vo-0000044" |
| 9608 | + } |
| 9609 | + ], |
| 9610 | + "user": "https://immunespace.org/" |
| 9611 | + } |
| 9612 | + ] |
9567 | 9613 | }, |
9568 | 9614 | { |
9569 | 9615 | "activity_status": "active", |
|
0 commit comments